Cytotoxic T lymphocyte antigen-4 (CTLA-4) expression in chordoma and tumor-infiltrating lymphocytes (TILs) predicts prognosis of spinal chordoma

ConclusionsTargeting CTLA-4 may be a potential novel therapeutic strategy for chordoma patients.

Source: Clinical and Translational Oncology - October 21, 2020 Category: Cancer & Oncology Source Type: research